Heat Biologics (HTBX) Misses Q1 EPS by 8c

Heat Biologics (NASDAQ: HTBX) reported Q1 EPS of ($0.57), $0.08 worse than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Heat Biologics (HTBX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Radnostix revenue falls 27% amid product recalls and FDA actions
• Pulmatrix (PULM) Reports Q2 Loss of $0.29